Abstract:The interaction between Nitisinone (NTBC) and bovine serum albumin (BSA) as the transport protein in a circulating system was investigated for the first time utilizing various analytical (UV–Vis spectrophotometry, fluorescence spectroscopy, dynamic light scattering, and differential scanning calorimetry) and computational (molecular docking and molecular dynamics simulations) methods. The BSA fluorescence intensity was quenched upon interaction with NTBC, and the quenching mechanism was observed as static. The interaction between NTBC and BSA was examined at 288 K, 298 K, and 308 K where the binding constants were found to be 1.44 × 10 5 ± 0.22 M −1 , 5.18 × 10 4 ± 0.20 M −1 , and 3.02 × 10 4 ± 0.22 M −1 respectively, suggesting an intermediate binding affinity between NTBC and BSA. Changes in the microenvironment surrounding tryptophan and tyrosine residues of BSA were elucidated using 3-D fluorescence spectroscopy. Thermodynamic studies revealed the calculated values of ΔH = − 54.34 ± 5 kJ/mol and ΔS = − 0.0908 ± 0.24 kJ/mol K −1 , indicating the involvement of van der Waals forces and hydrogen bonds in the interaction between NTBC and BSA. Moreover, the interaction's spontaneous nature was evidenced by negative ΔG values across all temperatures. Using dynamic light scattering, it was observed that higher NTBC concentrations led to a gradual rise in hydrodynamic diameter and notable aggregation of the NTBC-BSA complex. Moreover, changing signal values and shifted peaks of BSA, NTBC, and complex in differential scanning calorimetry curves, meant there were molecular interactions between the NTBC and BSA. In silico approaches also elucidated how NTBC binds to active sites on BSA, further supporting other findings. Moreover, molecular docking studies offer a more profound insight into the changing dynamics of hydrophobic, hydrogen, and halogen bonding involved in stabilizing the NTBC-BSA complex.

Binding Mechanism of the Tyrosine-Kinase Inhibitor Nilotinib to Human Serum Albumin Determined by 1 H STD NMR, 19 F NMR, and Molecular Modeling

Molecular Simulations on Dynamic Binding of Ibuprofen Onto Site II of Human Serum Albumin: One Potential Way Analysis

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Spectroscopic and Molecular Docking Studies of Binding Interaction of Gefitinib, Lapatinib and Sunitinib with Bovine Serum Albumin (BSA).

Investigating the Effect of Tyrosine Kinase Inhibitors on the Interaction between Human Serum Albumin by Atomic Force Microscopy

Elucidation of the interaction mechanism of olmutinib with human alpha-1 acid glycoprotein: insights from spectroscopic and molecular modeling studies

Domain-specific Interactions Between MLN8237 and Human Serum Albumin Estimated by STD and WaterLOGSY NMR, ITC, Spectroscopic, and Docking Techniques

Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking

Characterization of the binding of an anticancer drug, lapatinib to human serum albumin

Interaction of Nobiletin with Human Serum Albumin Studied Using Optical Spectroscopy and Molecular Modeling Methods

Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor

Human Serum Albumin Interaction With Formononetin Studied Using Fluorescence Anisotropy, Ft-Ir Spectroscopy, And Molecular Modeling Methods

In Vitro Characterization for Human Serum Albumin Binding Sorafenib, A Multi Kinase Inhibitor: Spectroscopic Study

Interaction of an anticancer drug, gefitinib with human serum albumin: insights from fluorescence spectroscopy and computational modeling analysis

Exploring the molecular basis of tucatinib interaction with human serum albumin: A spectroscopic and computational analysis

A Study of the Mechanism of Binding Between Neratinib and MAD2L1 Based on Molecular Simulation and Multi-spectroscopy Methods.

Investigation of the Interaction Between Naringin and Human Serum Albumin

Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy

Unraveling the interaction mechanism between orphan drug Nitisinone and bovine serum albumin through spectroscopic and in silico approaches

Binding Interaction of Sorafenib with Bovine Serum Albumin: Spectroscopic Methodologies and Molecular Docking.

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.